Kayon Partners is a venture firm that focuses on early to growth-stage investments in companies that disrupt their marketplaces through innovation. The firm typically engages in Seed, Series A, Convertible Note, and Series E rounds, providing capital and strategic support to entrepreneurial leaders as they transform ideas into market-leading businesses.
Notable portfolio companies include Fundation Group, Intarcia Therapeutics, and Symbiont. Founded in 2016 by Steve Garrow, Timothy Mitrovich, and David Vogel, Kayon Partners emphasizes a hands-on investment philosophy, leveraging their expertise to offer unique value-add services that help startups scale effectively.
Kayon Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count2
Total Portfolio Exits1
Top Investment Stages
Pre-Seed1 (25.0%)
Seed1 (25.0%)
Series A1 (25.0%)
Series E1 (25.0%)
Stage Mix
Pre-Seed 25%Seed 25%Series A 25%Series E 25%
Concentration shown as share of disclosed investments by stage.
